| Original language | English (US) |
|---|---|
| Pages (from-to) | 828-830 |
| Number of pages | 3 |
| Journal | JAMA cardiology |
| Volume | 4 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2019 |
| Externally published | Yes |
Bibliographical note
Funding Information:Conflict of Interest Disclosures: Dr Fonarow reports research funding from the National Institutes of Health and personal fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis, outside the submitted work. Dr Navar reports grants and personal fees from Amarin, Amgen, Regeneron, and Sanofi; personal fees from Novo Nordisk and AstraZeneca; and grants from Janssen, outside the submitted work. Dr Yancy reports spousal employment with Abbott Inc. No other disclosures were reported.